Cargando…
Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
Glioblastoma (GBM) is the most aggressive malignant brain tumour, with a median survival of 3 months without treatment and 15 months with treatment. Early GBM diagnosis can significantly improve patient survival due to early treatment and management procedures. Magnetic resonance imaging (MRI) using...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634494/ https://www.ncbi.nlm.nih.gov/pubmed/34868634 http://dx.doi.org/10.1093/rb/rbab062 |